ADPT
Adaptive Biotechnologies Corp
NASDAQ · Healthcare · Biotechnology · US
$23.95
−0.29%Leverage
- Debt / equity
- 2.87x
- Net debt / equity
- 1.68x
- Debt / assets
- 0.64x
- Debt / EBITDA
- -25.72x
- Net debt / EBITDA
- -15.07x
Liquidity & coverage
- Current ratio
- 4.79x
- Quick ratio
- 4.68x
- Cash ratio
- 3.92x
- Interest coverage
- -3.26x
- EBITDA / interest
- -1.39x
- Working capital
- $332.9M
Cash & dividend
- FCF / debt
- -0.06x
- Cash flow / debt
- -0.05x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026